
Boehringer Ingelheim will kick off its pharma investments in 2016 with a half a billion Euro outlay and plans to …

Many of the biologic drugs on the market today contain sugar molecule components that in some patients could undermine their …
UK biologics manufacturing specialist Eden Biodesign has been bought by US drugmaker Watson Pharmaceuticals in a $15 million deal. The …
Sanofi-Aventis will spend 200 million euros to convert one of its facilities near Paris into a biotechnology facility which is …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

